Simple blood test may spot preeclampsia risk before symptoms appear
NCT ID NCT07467226
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a protein called Cadherin-6 in the blood of pregnant women could help predict preeclampsia, a dangerous condition involving high blood pressure. Researchers measured Cadherin-6 levels in 150 women between 15 and 20 weeks of pregnancy and tracked who later developed preeclampsia. The goal is to find a simple test that identifies at-risk women early, so steps like low-dose aspirin can be started to reduce harm.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CADHERIN-6 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Canan Soyer Çalışkan
Samsun, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a placental protein unlock the mystery of preeclampsia?
- Tiny particles in the blood may warn of dangerous pregnancy high blood pressure
- Vitamin d may cut risk of repeat preeclampsia in High-Risk pregnancies
- Depression drug may mend blood vessels damaged by preeclampsia
- Postpartum blood pressure control may stop preeclampsia from leading to lifelong hypertension
- Genetic clues to severe preeclampsia could transform early detection